Professur für Hepatologie

A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results (2021) Wein A, Stöhr R, Kersting S, Siebler J, Merkel S, Busse D, Wolff K, et al. Journal article Muscle‐derived cytokines reduce growth, viability and migratory activity of pancreatic cancer cells (2021) Schwappacher R, Dieterich W, Reljic D, Pilarsky C, Mukhopadhyay D, Chang DK, Biankin A, et al. Journal article Combined de‐repression of chemoresistance associated mitogen‐activated protein kinase 14 and activating transcription factor 2 by loss of microrna‐622 in hepatocellular carcinoma (2021) Fritz V, Malek L, Gaza A, Wormser L, Appel M, Kremer A, Thasler WE, et al. Journal article THE AMOUNT OF LIVER TISSUE IS ESSENTIAL FOR ACCURATE HISTOLOGICAL STAGING IN PATIENTS WITH AUTOIMMUNE HEPATITIS (2021) Vetter M, Kremer A, Agaimy A, Konturek PC, Pfeifer L, Neurath M, Zopf S, Siebler J Journal article Endoscopic recanalization of complete esophageal obstruction (2021) Vitali F, Naegel A, Pfeifer L, Goetz M, Neurath M, Rath T, Siebler J Journal article The Ominous Ouzo Party - A Case Series of Four Patients with Accidental Alkali Ingestion (2021) Vetter M, Rath T, Siebler J, Waldner M, Neurath M, Pfeifer L Journal article Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy (2021) Dietz J, Di Maio VC, de Salazar A, Merino D, Vermehren J, Paolucci S, Kremer A, et al. Journal article Safety analysis of the run-in phase (1st and 2nd cohort) of the IMMUNIB trial (AIO-HEP-0218/ass) - An open-label, single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced stage HCC (2020) Vogel A, Mueller DW, De Toni E, Siegler GM, Lindig U, Mueller T, Schultheiss M, et al. Conference contribution Efficiency and Toxicity of Lenvatinib in Advanced HCC in Later Treatment Lines (2020) Jefremow A, Wiesmüller M, Rouse RA, Dietrich P, Kremer A, Waldner M, Neurath M, Siebler J Conference contribution Beyond the border: The use of lenvatinib in advanced hepatocellular carcinoma after different treatment lines: A retrospective analysis (2020) Jefremow A, Wiesmüller M, Rouse RA, Dietrich P, Kremer A, Waldner M, Neurath M, Siebler J Journal article